BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2025 10:33:15 AM | Browse: 132 | Download: 497
 |
Received |
|
2024-09-10 20:45 |
|
Peer-Review Started |
|
2024-09-10 20:45 |
|
First Decision by Editorial Office Director |
|
2024-10-28 07:57 |
|
Return for Revision |
|
2024-10-28 07:57 |
|
Revised |
|
2024-11-09 19:41 |
|
Publication Fee Transferred |
|
2024-11-12 16:21 |
|
Second Decision by Editor |
|
2024-12-12 02:40 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-12-12 06:59 |
|
Articles in Press |
|
2024-12-12 06:59 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-12-19 02:15 |
|
Publish the Manuscript Online |
|
2025-02-14 10:33 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Assessment of new pathological markers in early stage colon cancer: Insights and limitations
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Bulent Erdogan, Fatma Elif Usturalı Keskin, Erkan Özcan, Ahmet Küçükarda, Ali Kaan Güren, Osman Köstek, Bekir Muhammet Hacioglu and Hilmi Kodaz |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hilmi Kodaz, Professor, Department of Medical Oncology, Acibadem Eskisehir Hospital, Hosnudiye District, Eskibaglar Street, No. 19 Tepebası, Eskisehir 26130, Türkiye. hilmikodaz@hotmail.com |
| Key Words |
Colon cancer; Early stage; Risk factors; New pathological markers; Tumor-stroma ratio; Tumor infiltrating lymphocytes; Crohn-like reaction; Desmoid reaction; Poorly differentiated clusters |
| Core Tip |
When their associations with the pathological marker in the risk group were evaluated, it was found that there was a significant correlation between the presence of poorly differentiated clusters (PDC) and the presence of PDC grade 3 and advanced T stage. This showed us that PDC is one of the markers to be used in cases where these risk factors are insufficient. |
| Publish Date |
2025-02-14 10:33 |
| Citation |
Erdogan B, Usturalı Keskin FE, Özcan E, Küçükarda A, Güren AK, Köstek O, Hacioglu BM, Kodaz H. Assessment of new pathological markers in early stage colon cancer: Insights and limitations. World J Gastrointest Oncol 2025; 17(3): 101325 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i3/101325.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i3.101325 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
